白血病·淋巴瘤
白血病·淋巴瘤
백혈병·림파류
JOURNAL OF LEUKEMIA & LYMPHOMA
2011年
4期
206-208,217
,共4页
高琳滢%毛平%应逸%杜庆华%陈晓燕
高琳瀅%毛平%應逸%杜慶華%陳曉燕
고림형%모평%응일%두경화%진효연
ES/DCDF探针%LSI9q34探针%白血病,髓样,慢性%序列缺失
ES/DCDF探針%LSI9q34探針%白血病,髓樣,慢性%序列缺失
ES/DCDF탐침%LSI9q34탐침%백혈병,수양,만성%서렬결실
ES/DCDF probe%LSI 9q34 probe%Leukemia,myeloid,chronic%Sequence deletion
目的 研究慢性粒细胞性白血病(CML)患者衍生9号染色体[der(9)]部分序列缺失情况,探讨LSI 9q34探针在检测der(9)缺失中的联合应用价值.方法 对52例CML患者采用不加任何刺激剂的骨髓进行24 h短期培养法制备染色体,吉姆萨显带进行核型分析.应用ES/DCDF探针及LSI 9q34探针对骨髓间期细胞进行荧光原位杂交,并检测der(9)部分序列缺失.结果 52例中经ES/DCDF探针检测全部为ber-abl融合基因阳性,其中12例患者伴有der(9)部分缺失,占23.0%,经LSI 9q34探针检测有11例患者伴有der(9)部分缺失.结论 LSI9q34探针在判断CML患者是否伴有der(9)缺失方面有较好的特异性.伴有缺失的患者疾病进展较快,预后较差,甲磺酸依马替尼治疗不能完全逆转其负性作用,建议所有bcr-abl融合基因阳性的CML患者均应行 LSI 9q34探针检测,以指导临床治疗.
目的 研究慢性粒細胞性白血病(CML)患者衍生9號染色體[der(9)]部分序列缺失情況,探討LSI 9q34探針在檢測der(9)缺失中的聯閤應用價值.方法 對52例CML患者採用不加任何刺激劑的骨髓進行24 h短期培養法製備染色體,吉姆薩顯帶進行覈型分析.應用ES/DCDF探針及LSI 9q34探針對骨髓間期細胞進行熒光原位雜交,併檢測der(9)部分序列缺失.結果 52例中經ES/DCDF探針檢測全部為ber-abl融閤基因暘性,其中12例患者伴有der(9)部分缺失,佔23.0%,經LSI 9q34探針檢測有11例患者伴有der(9)部分缺失.結論 LSI9q34探針在判斷CML患者是否伴有der(9)缺失方麵有較好的特異性.伴有缺失的患者疾病進展較快,預後較差,甲磺痠依馬替尼治療不能完全逆轉其負性作用,建議所有bcr-abl融閤基因暘性的CML患者均應行 LSI 9q34探針檢測,以指導臨床治療.
목적 연구만성립세포성백혈병(CML)환자연생9호염색체[der(9)]부분서렬결실정황,탐토LSI 9q34탐침재검측der(9)결실중적연합응용개치.방법 대52례CML환자채용불가임하자격제적골수진행24 h단기배양법제비염색체,길모살현대진행핵형분석.응용ES/DCDF탐침급LSI 9q34탐침대골수간기세포진행형광원위잡교,병검측der(9)부분서렬결실.결과 52례중경ES/DCDF탐침검측전부위ber-abl융합기인양성,기중12례환자반유der(9)부분결실,점23.0%,경LSI 9q34탐침검측유11례환자반유der(9)부분결실.결론 LSI9q34탐침재판단CML환자시부반유der(9)결실방면유교호적특이성.반유결실적환자질병진전교쾌,예후교차,갑광산의마체니치료불능완전역전기부성작용,건의소유bcr-abl융합기인양성적CML환자균응행 LSI 9q34탐침검측,이지도림상치료.
Objective To study the frequency of the derivative chromosome 9 [der(9)] deletion among patients with chronic myeloid leukemia (CML), and explore the application value of local-specific inspector (LSI) 9q34 probe in detect the der (9) deletion. Methods Cytogenetic analysis was performed by 24 h unstimulated culture, GTG banding and karyotype. Dual colour/dual fusion or extra signal(ES) DNA probe was used to perform interphase-FISH for the detection of bcr-abl fusion gene in 52 patients with CML. LSI 9q34 DNA probe was used to detect der(9) deletion. Results FISH results showed bcr-abl fusion gene existed in all 52 patients with CML. der(9) deletion was detected in 12 patients with ES/DCDF probe, but only in 11 patients with LSI 9q34 probe. Conclusion It's more efficient in detection of der(9) deletion with LSI 9q34 probe. Deletion of der(9) might be a poor prognostic factor for CML patients, and LSI 9q34 probe should be used in all the CML patients with positive bcr-abl fusion gene.